Basic information Safety Supplier Related

2-Bromoimidazo[2,1-b][1,3,4]thiadiazole

Basic information Safety Supplier Related

2-Bromoimidazo[2,1-b][1,3,4]thiadiazole Basic information

Product Name:
2-Bromoimidazo[2,1-b][1,3,4]thiadiazole
Synonyms:
  • 2-Bromoimidazo[2,1-b][1,3,4]thiadiazole
  • Imidazo[2,1-b]-1,3,4-thiadiazole, 2-bromo-
CAS:
1137142-58-5
MF:
C4H2BrN3S
MW:
204.05
Mol File:
1137142-58-5.mol
More
Less

2-Bromoimidazo[2,1-b][1,3,4]thiadiazole Chemical Properties

Density 
2.34±0.1 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
0.74±0.50(Predicted)
Appearance
Light yellow to brown Solid
More
Less

2-Bromoimidazo[2,1-b][1,3,4]thiadiazole Usage And Synthesis

Synthesis

107-20-0

37566-39-5

1137142-58-5

The general procedure for the synthesis of 2-bromoimidazo[2,1-b][1,3,4]thiadiazole from chloroacetaldehyde and 2-amino-5-bromo-1,3,4-thiadiazole was as follows: 1. Preparation of Intermediate 3: To an aqueous (27 mL) suspension of 2-amino-5-bromo-1,3,4-thiadiazole (1.65 g, 9.15 mmol) was added a 50% wt aqueous chloroacetaldehyde solution (1.7 mL). 2. The reaction mixture was stirred under reflux conditions for 10 hours. 3. Subsequently, 1.5 equivalents of chloroacetaldehyde (1.7 mL) was added again and stirring was continued until the feedstock was completely consumed (approximately 20 hours). 4. Upon completion of the reaction, the mixture was cooled to room temperature and neutralized with saturated aqueous sodium bicarbonate. 5. The reaction mixture was extracted with dichloromethane (3 x 30 mL) and the organic layers were combined. 6. The organic layer was dried with anhydrous sodium sulfate, followed by evaporation of the solvent under reduced pressure. 7. The crude product was ground with ether to give 2-bromoimidazo[2,1-b][1,3,4]thiadiazole as a white solid. 8. The mother liquor was further purified by fast chromatography (Biotage, eluent: ethyl acetate/hexane, 3:7 to 7:3) to obtain another batch of the target compounds in a total yield of 20%. Product characterization: 1H NMR (300 MHz, CDCl3): δ 7.64 (s, 1H), 7.24 (s, 1H). MS (ES+) m/z: 204 (M + H)+ (MW: 204.05).

References

[1] Patent: WO2009/40552, 2009, A2. Location in patent: Page/Page column 51
[2] Patent: WO2010/112874, 2010, A1. Location in patent: Page/Page column 53
[3] Patent: WO2010/12345, 2010, A1. Location in patent: Page/Page column 53-54

2-Bromoimidazo[2,1-b][1,3,4]thiadiazoleSupplier

Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
13761987713
Email
hxzheng@sunwaypharm.cn
NovoChemy Ltd.
Tel
021-31261262/ 49 (0)17662837245
Email
sales@novochemy.com
Shanghai Topbiochem Technology Co., Ltd
Tel
+86-21-60341587
Email
sales@topbiochem.com
9ding chemical ( Shanghai) Limited
Tel
4009209199
Email
sales@9dingchem.com
ShangHai AmK Pharmaceutical Technology Co., Ltd.
Tel
微信 17321281695 18019252918
Email
sale@amkchem.com
More
Less